Sezai, Akira <br/><br/>
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Nov 2012 
 - 1241-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-685X 
<br/><br/><label>Standard No.: </label>10.1016/j.jtcvs.2012.06.042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenergic beta-Antagonists--administration & dosage<br/>Aged<br/>Aged, 80 and over<br/>Anti-Arrhythmia Agents--administration & dosage<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antioxidants--administration & dosage<br/>Arginine--analogs & derivatives<br/>Atrial Fibrillation--blood<br/>Biomarkers--blood<br/>Bisoprolol--administration & dosage<br/>C-Reactive Protein--metabolism<br/>Coronary Artery Bypass--adverse effects<br/>Creatine Kinase, MB Form--blood<br/>Drug Administration Schedule<br/>Fatty Acid Binding Protein 3<br/>Fatty Acid-Binding Proteins--blood<br/>Female<br/>Hemodynamics--drug effects<br/>Humans<br/>Infusions, Intravenous<br/>Japan<br/>Male<br/>Middle Aged<br/>Morpholines--administration & dosage<br/>Natriuretic Peptide, Brain--blood<br/>Pilot Projects<br/>Serum Amyloid P-Component--metabolism<br/>Single-Blind Method<br/>Time Factors<br/>Treatment Outcome<br/>Troponin I--blood<br/>Urea--administration & dosage